Cigna (CI) Stock Forecast & Price Target

Compare

3,571 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CI Analyst Ratings

Strong Buy

7 Buy

1 Hold

0 Sell

Based on 8 analysts giving stock ratings to

Cigna

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CI Stock 12 Month Forecast

Average Price Target

$328.75

▲(20.99% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $328.75 with a high forecast of $378.00 and a low forecast of $305.00. The average price target represents a 20.99% change from the last price of $271.71.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"242":"$242","379":"$379","276.25":"$276.3","310.5":"$310.5","344.75":"$344.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":378,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$378.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":328.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$328.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":305,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$305.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[242,276.25,310.5,344.75,379],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,271.54,279.7292307692308,287.91846153846154,296.10769230769233,304.2969230769231,312.48615384615385,320.67538461538464,328.8646153846154,337.05384615384617,345.24307692307696,353.4323076923077,361.6215384615385,369.8107692307692,{"y":378,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,271.54,275.94076923076926,280.3415384615385,284.7423076923077,289.14307692307693,293.5438461538462,297.9446153846154,302.3453846153846,306.74615384615385,311.1469230769231,315.54769230769233,319.9484615384615,324.34923076923076,{"y":328.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,271.54,274.11384615384617,276.6876923076923,279.26153846153846,281.8353846153846,284.40923076923076,286.9830769230769,289.5569230769231,292.13076923076926,294.7046153846154,297.27846153846156,299.8523076923077,302.42615384615385,{"y":305,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":288.284,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":302.629,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":325.927,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.042,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":310.162,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.851,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":259.454,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.685,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.044,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":272.041,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.23,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.54,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$378.00

Average Price Target$328.75

Lowest Price Target$305.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Andrew Mok CFA

Barclays

$305

Buy

12.25%

Upside

Reiterated

02/05/26

Barclays Reaffirms Their Buy Rating on Cigna (CI)

Charles Rhyee

TD Cowen

$333

Buy

22.56%

Upside

Reiterated

02/04/26

Cigna (CI) Receives a Buy from TD Cowen

Jason Cassorla

Guggenheim

$318

Buy

17.04%

Upside

Reiterated

02/02/26

Guggenheim Keeps Their Buy Rating on Cigna (CI)

Lance Wilkes

Bernstein

$307

Hold

12.99%

Upside

Reiterated

01/27/26

Bernstein Sticks to Their Hold Rating for Cigna (CI)

Ben Hendrix

RBC Capital

$344

Buy

26.61%

Upside

Reiterated

01/22/26

Cigna (CI) Gets a Buy from RBC Capital

Ann Hynes

Mizuho Securities

$307→$325

Buy

19.61%

Upside

Reiterated

01/09/26

Cigna price target raised to $325 from $307 at MizuhoCigna price target raised to $325 from $307 at Mizuho

David S Macdonald

Truist Financial

$310→$320

Buy

17.77%

Upside

Reiterated

01/05/26

Cigna price target raised to $320 from $310 at TruistCigna price target raised to $320 from $310 at Truist

Kevin Fischbeck

Bank of America Securities

$269.6→$378

Buy

39.12%

Upside

Reiterated

12/10/25

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI) and Harmony Biosciences Holdings (NASDAQ: HRMY)

Lisa Gill

J.P. Morgan

$428→$375

Buy

38.01%

Upside

Reiterated

11/04/25

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC) and Cigna (NYSE: CI)

Scott Fidel

Goldman Sachs

$370→$330

Buy

21.45%

Upside

Reiterated

11/04/25

Cigna price target lowered to $330 from $370 at Goldman SachsCigna price target lowered to $330 from $370 at Goldman Sachs

Stephen Baxter

Wells Fargo

$354→$300

Hold

10.41%

Upside

Reiterated

11/04/25

Cigna (CI) Gets a Hold from Wells Fargo

John Ransom

Raymond James

$385→$350

Buy

28.81%

Upside

Reiterated

11/03/25

Cigna price target lowered to $350 from $385 at Raymond JamesCigna price target lowered to $350 from $385 at Raymond James

Erin Wright

Morgan Stanley

$390→$355

Buy

30.65%

Upside

Reiterated

10/31/25

Morgan Stanley Reaffirms Their Buy Rating on Cigna (CI)

Michael Wiederhorn

Oppenheimer

$365

Buy

34.33%

Upside

Reiterated

10/31/25

Cigna (CI) Gets a Buy from Oppenheimer

A.J. Rice

UBS

$340

Buy

25.13%

Upside

Reiterated

10/31/25

Cigna (CI) Gets a Buy from UBS

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Andrew Mok CFA

Barclays

$305

Buy

12.25%

Upside

Reiterated

02/05/26

Barclays Reaffirms Their Buy Rating on Cigna (CI)

Charles Rhyee

TD Cowen

$333

Buy

22.56%

Upside

Reiterated

02/04/26

Cigna (CI) Receives a Buy from TD Cowen

Jason Cassorla

Guggenheim

$318

Buy

17.04%

Upside

Reiterated

02/02/26

Guggenheim Keeps Their Buy Rating on Cigna (CI)

Lance Wilkes

Bernstein

$307

Hold

12.99%

Upside

Reiterated

01/27/26

Bernstein Sticks to Their Hold Rating for Cigna (CI)

Ben Hendrix

RBC Capital

$344

Buy

26.61%

Upside

Reiterated

01/22/26

Cigna (CI) Gets a Buy from RBC Capital

Ann Hynes

Mizuho Securities

$307→$325

Buy

19.61%

Upside

Reiterated

01/09/26

Cigna price target raised to $325 from $307 at MizuhoCigna price target raised to $325 from $307 at Mizuho

David S Macdonald

Truist Financial

$310→$320

Buy

17.77%

Upside

Reiterated

01/05/26

Cigna price target raised to $320 from $310 at TruistCigna price target raised to $320 from $310 at Truist

Kevin Fischbeck

Bank of America Securities

$269.6→$378

Buy

39.12%

Upside

Reiterated

12/10/25

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI) and Harmony Biosciences Holdings (NASDAQ: HRMY)

Lisa Gill

J.P. Morgan

$428→$375

Buy

38.01%

Upside

Reiterated

11/04/25

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC) and Cigna (NYSE: CI)

Scott Fidel

Goldman Sachs

$370→$330

Buy

21.45%

Upside

Reiterated

11/04/25

Cigna price target lowered to $330 from $370 at Goldman SachsCigna price target lowered to $330 from $370 at Goldman Sachs

Stephen Baxter

Wells Fargo

$354→$300

Hold

10.41%

Upside

Reiterated

11/04/25

Cigna (CI) Gets a Hold from Wells Fargo

John Ransom

Raymond James

$385→$350

Buy

28.81%

Upside

Reiterated

11/03/25

Cigna price target lowered to $350 from $385 at Raymond JamesCigna price target lowered to $350 from $385 at Raymond James

Erin Wright

Morgan Stanley

$390→$355

Buy

30.65%

Upside

Reiterated

10/31/25

Morgan Stanley Reaffirms Their Buy Rating on Cigna (CI)

Michael Wiederhorn

Oppenheimer

$365

Buy

34.33%

Upside

Reiterated

10/31/25

Cigna (CI) Gets a Buy from Oppenheimer

A.J. Rice

UBS

$340

Buy

25.13%

Upside

Reiterated

10/31/25

Cigna (CI) Gets a Buy from UBS

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

3 Months

xxx

Success Rate

19/30 ratings generated profit

Average Return

+4.50%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 63.33% of your transactions generating a profit, with an average return of +4.50% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

21/28 ratings generated profit

Average Return

+18.07%

a rating ―

Copying Scott Fidel's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +18.07% per trade.

2 Years

xxx

Success Rate

17/19 ratings generated profit

Average Return

+24.37%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 89.47% of your transactions generating a profit, with an average return of +24.37% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CI Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CI has received 11 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CI average Analyst price target in the past 3 months is 328.75.

Each month's total comprises the sum of three months' worth of ratings.

CI Financial Forecast

CI Earnings Forecast

The previous quarter’s earnings for CI were $4.64.

CI Sales Forecast

The previous quarter’s earnings for CI were $72.47B.

CI Stock Forecast FAQ

What is CI’s average 12-month price target, according to analysts?

Based on analyst ratings, Cigna Corp’s 12-month average price target is 328.75.

What is CI’s upside potential, based on the analysts’ average price target?

Cigna Corp has 20.99% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CI a Buy, Sell or Hold?

Cigna Corp has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.

What is Cigna Corp’s price target?

The average price target for Cigna Corp is 328.75. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $378.00 ,the lowest forecast is $305.00. The average price target represents 20.99% Increase from the current price of $271.71.

What do analysts say about Cigna Corp?

Cigna Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of CI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Cigna (CI) Stock Forecast & Price Target

CI Analyst Ratings

CI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cigna

CI Analyst Recommendation Trends

CI Financial Forecast

CI Earnings Forecast

CI Sales Forecast

CI Stock Forecast FAQ

Detailed List of Analyst Forecasts